New Four-Strain flu vaccine shows promise in massive chinese trial

NCT ID NCT04210349

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 33 times

Summary

This study tested whether a quadrivalent (four-strain) flu vaccine works as well as or better than a trivalent (three-strain) vaccine in over 7,000 people aged 6 months and older in China. The main goal was to see if the four-strain shot triggers a stronger immune response against both flu B lineages. Researchers also tracked side effects like injection site pain, fever, and other reactions to ensure the vaccine is safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number 1561000

    Kunming, 650022, China

  • Investigational Site Number 1561001

    Lincang, 677001, China

  • Investigational Site Number 1561002

    Lincang, 677001, China

  • Investigational Site Number 1561003

    Lincang, 677001, China

  • Investigational Site Number 1562000

    Zhengzhou, 450002, China

  • Investigational Site Number 1562001

    Shangqiu, 476000, China

  • Investigational Site Number 1562002

    Xinxiang, 453200, China

Conditions

Explore the condition pages connected to this study.